“Sandwich” Strategy to Intensify EGFR Blockade by Concurrent Tyrosine Kinase Inhibitor and Monoclonal Antibody Treatment in Highly Selected Patients

EGFR TKIs are not curative, and targeted resistance inevitably results in therapeutic failure. Additionally, there are numerous uncommon EGFR mutations that are insensitive to EGFR TKIs, and there is a lack of clinical strategies to overcome these limitations. EGFR TKI and mAbs target EGFR at differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Guoqing, Yan, Beibei, Guo, Yanan, Yang, Hang, Li, Jindong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321780/
https://www.ncbi.nlm.nih.gov/pubmed/35903676
http://dx.doi.org/10.3389/fonc.2022.952939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321780/
https://www.ncbi.nlm.nih.gov/pubmed/35903676
http://dx.doi.org/10.3389/fonc.2022.952939

Ejemplares similares